EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Reliable and rapid identification of terbinafine resistance in dermatophytic nail and skin infections

Gabriela Blanchard iD, Boyko Amarov, Marina Fratti, Karine Salamin, Olympia Bontems, Yun-Tsan Chang, Alina Marcela Sabou, Nathalie Künzle, Michel Monod, Emmanuella Guenova iD

Journal of the European Academy of Dermatology and Venereology · 2023-10 · 37 (10) · 2080-2089

DOI: 10.1111/jdv.19253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 03.07.2023. Verfasst von Gabriela Blanchard und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Lausanne University Hospital, CHUV, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Tinea, Arthrodermataceae, Skin Diseases, Infectious. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Academy of Dermatology and Venereology, University of Lausanne (SKINTEGRITY.CH collaborative research program)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fungal infections are the most frequent dermatoses. The gold standard treatment for dermatophytosis is the squalene epoxidase (SQLE) inhibitor terbinafine. Pathogenic dermatophytes resistant to terbinafine are an emerging global threat. Here, we determine the proportion of resistant fungal skin infections, analyse the molecular mechanisms of terbinafine resistance, and validate a method for its reliable rapid identification.

Methods

Between 2013 and 2021, we screened 5634 consecutively isolated Trichophyton for antifungal resistance determined by hyphal growth on Sabouraud dextrose agar medium containing 0.2 μg/mL terbinafine. All Trichophyton isolates with preserved growth capacity in the presence of terbinafine underwent SQLE sequencing. Minimum inhibitory concentrations (MICs) were determined by the broth microdilution method.

Results

Over an 8‐year period, the proportion of fungal skin infections resistant to terbinafine increased from 0.63% in 2013 to 1.3% in 2021. Our routine phenotypic in vitro screening analysis identified 0.83% ( n = 47/5634) of Trichophyton strains with in vitro terbinafine resistance. Molecular screening detected a mutation in the SQLE in all cases. Mutations L393F, L393S, F397L, F397I, F397V, Q408K, F415I, F415S, F415V, H440Y, or A 398 A 399 G 400 deletion were detected in Trichophyton rubrum. Mutations L393F and F397L were the most frequent. In contrast, all mutations detected in T. mentagrophytes/T. interdigitale complex strains were F397L, except for one strain with L393S. All 47 strains featured significantly higher MICs than terbinafine‐sensitive controls. The mutation‐related range of MICs varied between 0.004 and 16.0 μg/mL, with MIC as low as 0.015 μg/mL conferring clinical resistance to standard terbinafine dosing.

Conclusions

Based on our data, we propose MIC of 0.015 μg/mL as a minimum breakpoint for predicting clinically relevant terbinafine treatment failure to standard oral dosing for dermatophyte infections. We further propose growth on Sabouraud dextrose agar medium containing 0.2 μg/mL terbinafine and SQLE sequencing as fungal sporulation‐independent methods for rapid and reliable detection of terbinafine resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TineaArthrodermataceaeSkin Diseases, InfectiousHumansTerbinafineAntifungal AgentsAgarTrichophytonMicrobial Sensitivity TestsSqualene MonooxygenaseGlucose

Substanzen

TerbinafineAntifungal AgentsAgarSqualene MonooxygenaseGlucose

Autor:innen und Institutionen

  • Department of Dermatology, Lausanne University Hospital, CHUV, Lausanne, Switzerland.
  • Institute of Statistics and Econometrics, Sofia University "St. Kliment Ohridski," Faculty of Economics and Business Administration, Sofia, Bulgaria.
  • Laboratoire de Parasitologie et Mycologie Médicale, Plateau Technique de Microbiologie, University Hospital of Strasbourg, Strasbourg, France.
  • Dermatology Clinic, Monthey, Switzerland.
  • Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
  • Department of Dermatology, Hospital 12 de octubre, Medical School, University Complutense, Madrid, Spain.

ORCID-Profile: Gabriela Blanchard, Emmanuella Guenova

Förderung

  • European Academy of Dermatology and Venereology
  • University of Lausanne (SKINTEGRITY.CH collaborative research program).

Zitieren

APA

Blanchard, G., Amarov, B., Fratti, M., Salamin, K., Bontems, O., Chang, Y. T., Sabou, A. M., Künzle, N., Monod, M., & Guenova, E. (2023). Reliable and rapid identification of terbinafine resistance in dermatophytic nail and skin infections. Journal of the European Academy of Dermatology and Venereology, 37(10), 2080-2089. https://doi.org/10.1111/jdv.19253

Vancouver

Blanchard G, Amarov B, Fratti M, Salamin K, Bontems O, Chang YT, et al. Reliable and rapid identification of terbinafine resistance in dermatophytic nail and skin infections. Journal of the European Academy of Dermatology and Venereology. 2023;37(10):2080-2089. doi:10.1111/jdv.19253

BibTeX
@article{Blanchard2023,
  author = {Blanchard, Gabriela and Amarov, Boyko and Fratti, Marina and Salamin, Karine and Bontems, Olympia and Chang, Yun-Tsan and Sabou, Alina Marcela and Künzle, Nathalie and Monod, Michel and Guenova, Emmanuella},
  title = {Reliable and rapid identification of terbinafine resistance in dermatophytic nail and skin infections},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2023},
  volume = {37},
  number = {10},
  pages = {2080--2089},
  doi = {10.1111/jdv.19253}
}
Kostenlos starten →